Advancing Pharmacist Collaborative Care within Academic Health Systems

被引:13
作者
Awdishu, Linda [1 ,2 ]
Singh, Renu F. [1 ,2 ]
Saunders, Ila [1 ,2 ]
Yam, Felix K. [1 ,3 ]
Hirsch, Jan D. [1 ,4 ]
Lorentz, Sarah [1 ]
Atayee, Rabia S. [1 ,2 ]
Ma, Joseph D. [1 ,2 ]
Tsunoda, Shirley M. [1 ,2 ]
Namba, Jennifer [1 ,2 ]
Mnatzaganian, Christina L. [1 ,2 ]
Painter, Nathan A. [1 ,2 ]
Watanabe, Jonathan H. [1 ]
Lee, Kelly C. [1 ,2 ]
Daniels, Charles E. [1 ,2 ]
Morello, Candis M. [1 ,3 ]
机构
[1] Univ Calif, San Diego Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA
[2] Univ Calif, San Diego Hlth Syst, La Jolla, CA 92093 USA
[3] Vet Affairs San Diego Healthcare Syst, La Jolla, CA 92093 USA
[4] Univ Calif Irvine, Irvine Sch Pharm & Pharmaceut Sci, Irvine, CA 92697 USA
关键词
collaborative practice; clinical pharmacy; advanced practice pharmacist provider; MEDICATION-THERAPY MANAGEMENT; RISK; INTERVENTIONS; PATTERNS; PAIN; HYPERTENSION; DEPRESSION; REDUCTION; PHYSICIAN; KETAMINE;
D O I
10.3390/pharmacy7040142
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: The scope of pharmacy practice has evolved over the last few decades to focus on the optimization of medication therapy. Despite this positive impact, the lack of reimbursement remains a significant barrier to the implementation of innovative pharmacist practice models. Summary: We describe the successful development, implementation and outcomes of three types of pharmacist collaborative care models: (1) a pharmacist with physician oversight, (2) pharmacist-interprofessional teams and (3) physician-pharmacist teams. The outcome measurement of these pharmacist care models varied from the design phase to patient volume measurement and to comprehensive quality dashboards. All of these practice models have been successfully funded by affiliated health systems or grants. Conclusions: The expansion of pharmacist services delivered by clinical faculty has several benefits to affiliated health systems: (1) significant improvements in patient care quality, (2) access to experts in specialty areas, and (3) the dissemination of outcomes with national and international recognition, increasing the visibility of the health system.
引用
收藏
页数:14
相关论文
共 48 条
[1]  
Amin Priya, 2014, J Pain Palliat Care Pharmacother, V28, P233, DOI 10.3109/15360288.2014.938881
[2]   Patterns of Palliative Care Pharmacist Interventions and Outcomes as Part of Inpatient Palliative Care Consult Service [J].
Atayee, Rabia S. ;
Sam, Andrew M. ;
Edmonds, Kyle P. .
JOURNAL OF PALLIATIVE MEDICINE, 2018, 21 (12) :1761-1767
[3]   Development of an Ambulatory Palliative Care Pharmacist Practice [J].
Atayee, Rabia Samady ;
Best, Brookie M. ;
Daniels, Charles E. .
JOURNAL OF PALLIATIVE MEDICINE, 2008, 11 (08) :1077-1082
[4]   A Primer on Quality Assurance and Performance Improvement for Interprofessional Chronic Kidney Disease Care: A Path to Joint Commission Certification [J].
Awdishu, Linda ;
Moore, Teri ;
Morrison, Michelle ;
Turner, Christy ;
Trzebinska, Danuta .
PHARMACY, 2019, 7 (03)
[5]   A Cluster Randomized Trial to Evaluate Physician/Pharmacist Collaboration to Improve Blood Pressure Control [J].
Carter, Barry L. ;
Bergus, George R. ;
Dawson, Jeffrey D. ;
Farris, Karen B. ;
Doucette, William R. ;
Chrischilles, Elizabeth A. ;
Hartz, Arthur J. .
JOURNAL OF CLINICAL HYPERTENSION, 2008, 10 (04) :260-271
[6]   Physician and Pharmacist Collaboration to Improve Blood Pressure Control [J].
Carter, Barry L. ;
Ardery, Gail ;
Dawson, Jeffrey D. ;
James, Paul A. ;
Bergus, George R. ;
Doucette, William R. ;
Chrischilles, Elizabeth A. ;
Franciscus, Carrie L. ;
Xu, Yinghui .
ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (21) :1996-2002
[7]  
Centers for Disease Control and Prevention, 2018, U CAL SAN DIEG PHARM
[8]  
Commission T.J., 2019, SOURCE, V17, P1
[9]  
Foundatiote pon C.H.-C, 2004, USING COMPUTERIZED R
[10]  
Greer N., 2015, PHARM LED CHRONIC DI